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A methodology on how to
create a real-life relevant risk
profile for a given nanomaterial
With large amounts of nanotoxicology studies delivering contradicting results and a complex, moving
regulatory framework, potential risks surrounding nanotechnology appear complex and confusing. Many
researchers and workers in different sectors are dealing with nanomaterials on a day-to-day basis, and have a
requirement to define their assessment/management needs. This paper describes an industry-tailored
strategy for risk assessment of nanomaterials and nano-enabled products, which builds on recent research
outcomes. The approach focuses on the creation of a risk profile for a given nanomaterial (e.g., determine
which materials and/or process operation pose greater risk, where these risks occur in the lifecycle, and the
impact of these risks on society), using state-of-the-art safety assessment approaches/tools (ECETOC TRA,
Stoffenmanager Nano and ISO/TS 12901-2:2014). The developed nanosafety strategy takes into account
cross-sectoral industrial needs and includes (i) Information Gathering: Identification of nanomaterials and
hazards by a demand-driven questionnaire and on-site company visits in the context of human and
ecosystem exposures, considering all companies/parties/downstream users involved along the value chain;
(ii) Hazard Assessment: Collection of all relevant and available information on the intrinsic properties of the
substance (e.g., peer reviewed (eco)toxicological data, material safety data sheets), as well as identification of
actual recommendations and benchmark limits for the different nano-objects in the scope of this projects;
(iii) Exposure Assessment: Definition of industry-specific and application-specific exposure scenarios taking
into account operational conditions and risk management measures; (iv) Risk Characterisation: Classifica-
tion of the risk potential by making use of exposure estimation models (i.e., comparing estimated exposure
levels with threshold levels); (v) Refined Risk Characterisation and Exposure Monitoring: Selection of
individual exposure scenarios for exposure monitoring following the OECD Harmonized Tiered Approach
to refine risk assessment; (vi) Risk Mitigation Strategies: Development of risk mitigation actions focusing on
risk prevention.By Christa Schimpel,
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ãINTRODUCTION
In the last decade, nanotechnology
entered the policy arena as a technology
that is simultaneously threatening and
promising.1 The combination of size,
structure and physical/chemical prop-
erties of nanomaterials (NMs) offer
remarkable technological advances
and innovations but may also entail C. et al1., A methodology on how to create a
, http://dx.doi.org/10.1016/j.jchas.2017.06.002
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onet.at).
anoNet Forschungsgesellschaft mbH, Graz
anotechnology Industries Association, Br
otechnology Industries Association, Bruss
alia Research & Innovation, Min˜ano, Spai
alia Research & Innovation, Min˜ano, Spa
 2017 Published by Elsevier Inc. on behalf of Division ofnew risks for human health and the
environment.2–4 Thus, an appropriate
management of nano-related risks have
been identified by the EU Commission
as a vital empowering issue for the suc-
cess of NMs and nanotechnologies.5
One bottleneck that hinders the
safe and sustainable development of
nano-innovations in various industrial
sectors is that nano-specific legislative real-life relevant risk profile for a given
az, Austria
, Austria.
ussels, Belgium.
els, Belgium.
n.
in.
 Chemical Health and Safety of the American
Chemical Society.
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JCHAS-943; No of Pages 12measures at the EU level are currently
vague; while a decade of research in
nanotoxicology has failed to identify
specific modes of action for nanomater-
ial toxicity,6 the regulatory framework
has been growing disorderly, creating
an uncertain environment for
industry.7,8
In the European Union, NMs are
considered as a chemical substance
and therefore fall in the existing regu-
latory framework of regulation 1907/
20061 concerning the Registration,
Evaluation, Authorisation and Restric-
tion of Chemicals (REACH). Since
REACH does not explicitly integrate
provisions regarding NMs, they are
bound to registration like other sub-
stances. Since February 2012, regis-
trants can voluntarily declare that their
substance is in “nanomaterial form”
and with the Second Regulatory
Review on NMs produced by the Com-
mission in the same year, the regulator
promised improvements to the regis-
tration of such substances under
REACH, including potential amend-
ments of the Regulation’s annexes.
This process is currently under prog-
ress, but will not be ready for the 2018
registration deadline for substances
manufactured or imported in amounts
exceeding one ton a year as a two-year
standstill period applies.
In addition, several pieces of sectoral
European regulation directly target
NMs and nanotechnology (e.g., food
and novel foods, cosmetics, biocides,
electronic waste, etc.). To support a
harmonized understanding of what
constitutes a nanomaterial, the Eu
pean Commission has published a R
ommendation for a Definition o
nanomaterial (696/2011)2 wh
defines a nanomaterial as follows:
‘2. ‘Nanomaterial’ means a natu
incidental or manufactured mate
containing particles, in an unbo
state or as an aggregate or as 
agglomerate and where, for 50%
more of the particles in the num
size distribution, one or more exter
dimensions is in the size range 1 n
100 nm. In specific cases and wh
warranted by concerns for the envir
ment, health, safety or competitiven
the number size distribution thresh
of 50% may be replaced by a thresh
between 1 and 50%.’
While this definition has been ta
up in most of the European 
national legislation tackling N
there remains a variety of definiti
(e.g. NMs for food, etc.). A review
this definition is also currently at w
by the European Commission. Reg
tory measures specific to NMs ra
from labelling requirements to ad
tional testing and pre-mar
authorisation.
On top of this EU Framework, so
EU Member States, including Fran
Belgium, Denmark and Sweden, h
developed nanomaterial regis
which condition the manufactur
importation and distribution of N
to their prior registration in a natio
database.
As a consequence, researchers 
unsure how to work safely w
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1 EC, 2006. Regulation (EC) 1907
2006 of the European Parliamen
and of the Council on the Registration
Evaluation, Authorisation and Restric
tion of Chemicals (REACH), establish
ing a European Chemicals Agency
amending Directive 1999/45/EC and
repealing Council Regulation (EEC
No 793/93 and Commission Regula
tion (EC) No 1488/94 as well as Coun
cil Directive 76/769/EEC and Com
mission Directives 91/155/EEC, 93
67/EEC, 93/105/EC and 2000/21
EC. OJ L; http://eur-lex.europa.eu
legal-content/EN/TXT/PDF/?uri=
CELEX:02006R1907-20140410&
from=EN.
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NMs. Industry dealing with NMs has
to cope with an unstable and unreli-
able framework to develop safe and
legally compliant products, and con-
sumer and public confidence of emerg-
ing nano-innovations may severely be
affected.9
Another problem is that reliable tox-
icity information and data on the levels
of NMs that the worker, consumer and
environment may become exposed to
are either limited or non-existent.
Without such data, it is difficult to
quantify exposures and it beco
even more difficult to effecti
respond to any potential nano-rela
risks.10,11
Although relatively limited data
available, the fact remains that N
and/or nano-enabled products m
pose a risk depending on their po
tial hazard and exposure proper
Nonetheless, it cannot be conclu
that nano-related risks are higher c
pared to conventional materials/b
counterparts. Still, a strategic fra
work that can properly define 
nature of nano-related risks 
needed.12–14
According to legislation and the c
rent knowledge, NMs have to be t
ted the same way as chemical s
stances, which means the stand
information requirements and 
Chemical Safety Assessment (C
described in the Annexes VII–X
the REACH regulation shall 
applied. Quantitative risk estima
represents the most important fea
of a CSA. Under REACH, risk esti
tion/characterisation is defined as
comparison of exposure levels 
hazard levels leading to the calcula
of a Risk Characterization R
(RCR). However, in the case of N
quantitative risk assessment is not 
sible due to the fact that prese
neither agreed standardised, valida
and specific methods for measu
personal exposure (i.e., breathing z
measurements) to engineered NMs
available nor are there validated m
els providing quantitative estimate
human (worker and consumer)
environmental exposure.15 The tech
cal limitations of currently availa
sampling and analytical methods m
also raise issues and might not prop
sufficient sensitivity to properly as
very low exposure levels.16 The 
available guidance for exposure m
surement suggests that in addition
an appropriate characterisation of p
ticle size distribution, measureme
should at least encompass an ass
ment of mass, but where possible 
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/ 2 European Commission 2011 (2011/
696/EU). Commission recommenda
tion on the definition of nanomaterial
OJ L 275/38, 18 October 2011.
Journal oinclude number and/or surface a
concentration.17,18
Confronted with these limitation
was decided that the most sens
course of action is to focus on (i) q
itative risk assessment covering
-
.ate a real-life relevant risk profile for a given
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3Regulation 1272/2008 of the Euro-
pean Parliament and of the Council
of 16 December 2008 on classification,
labelling and packaging of substances
and mixtures, amending and repealing
Directive 67/548/EEC and 1999/45/
EC and amending Regulation (EC) No
1907/2006
4Directive 2012/19/EU of the Euro-
pean Parliament and of the Council of
4 July 2012 on waste electrical and elec-
tronic equipment (WEEE); http://
eur-lex.europa.eu/legal-content/en/
ALL/?uri=CELEX:32012L0019.
5Directive 2011/65/EU of the Euro-
pean Parliament end of the Council on
the Restriction of the use of Certain
Hazardous Substances in Electrical
and Electronic Equipment (RoHS2);
http://eur-lex.europa.eu/
legal-content/en/TXT/?
uri=CELEX:32011L0065.stages of the lifecycle, (ii) hazard/risk
avoidance rather than address them as
an exposure (exercising an appropriate
level of precaution) and (iii) strong
involvement of industry, risk managers
and relevant stakeholders.
In addition, input from (i) experts
in the NanoSafety Cluster (NSC)
community, (ii) EU institutions (e.g.,
ECHA), (iii) international organisa-
tions (e.g., OECD27), (iv) industry
initiatives (e.g., ECETOC28,29), (v)
European Center for Nanotoxicology
(EURO-NanoTox),54 and (vi) peer-
reviewed scientific literature, have
been considered to ensure consistency
at EU level and alignment to the state-
of-the-art.
In this framework, hazard/exposure
potentials are measured on scales
called “bands” using the control
banding approaches Stoffenmanager
Nano19 and ISO/TS 12901-2:2014.20
Additionally, risk values were calcu-
lated via computational risk screening
model ECETOC TRA.21
FRAMEWORK FOR DEVELOPING A
RISK PROFILE
In brief, the proposed nanosafety con-
cept was developed by linking the
strategies of hazard assessment, life
cycle assessment, and risk analysis
within the same toolbox. First, all
available information and data on
physicochemical properties, exposure,
toxicokinetics, fate, and hazard of
given NMs is collected to build general
exposure scenarios (case studies)
throughout the whole life cycle of the
NMs. Next, initial exposure estimates
are obtained on a PROC (process cat-
egory)-specific basis. For each PROC,
exposure values are calculated accord-
ing to the selected/assigned PROC-
class as well as several parameters such
as the frequency and duration of expo-
sure, the presence of a local exhaust
ventilation (LEV), etc. The final output
is a library of critical hotspots associ-
ated with initial exposure estimates,
which are universally applicable across
diverse industrial and consumer
sectors. This may help to develop miti-
gation plans designed to manage,
eliminate, or reduce risk to an accept-
able level and thus lowering thePlease cite this article in press as: Schimpel,
nanomaterial. J. Chem. Health Safety (2017)
Journal of Chemical Health & Safety, May/Jcommercialisation barrier for innova-
tive nanotechnology driven products.
The proposed concept is currently
used for the safety assessment in two
H2020 pilot line projects (INSPIRED
and Hi-Response) dealing with high
throughput synthesis and scale-up of
NMs for printed electronic applica-
tions. The following sections
(“Information gathering” to “Refined
risk characterisation and exposure
monitoring”) describe in more detail
the actions to be considered when
ensuring the responsible development
of NMs and nano-enabled products
(taking into account the whole inno-
vation life cycle; i.e.; cradle-to-grave
analysis) from an occupational and
environmental safety and health
perspective.
Applicable Regulatory Framework
In this context, the NMs used are sub-
ject to a series of European regulations
where their size may trigger additional
requirements. Because they are chem-
ical substances, NMs fall under general
term of “substance” in REACH and are
classified according to Regulation on
classification, labelling and packaging
(CLP).3 Discussions towards the mod-
ification of REACH annexes to intro-
duce the term “nanoform”, and
requirements to provide information
on the size, shape and surface modifi-
cation of individual nanoforms, are
ongoing and will eventually apply to
European nanomaterial manufac-
turers and importers.
Under REACH, the responsibility
falls on the registrant to assess the
hazards of the substance in the regis-
tration dossier. In other instances, reg-
ulations give the role of substance eval-
uation to European authorities and
make use of positive lists of authorized
substances (e.g. food, food contact
materials). When used in electronics,
NMs also need to comply with the C. et al1., A methodology on how to create a
, http://dx.doi.org/10.1016/j.jchas.2017.06.002
une 2017 Waste Electrical and Electronic Equip-
ment Directive (WEEE) – 2012/19/
EU4 and the Directive on the Restric-
tion of the use of Certain Hazardous
Substances in Electrical and Elec-
tronic Equipment (RoHS2) – 2011/
65/EU.5 In the WEEE directive from
2012, the legislator referred to the
2009 Opinion of the Scientific Com-
mittee on Emerging and Newly Identi-
fied Health Risks (SCENIHR) on ‘Risk
assessment of Products of
Nanotechnologies’22 which considers
that ‘when nanomaterials are firmly
embedded in large structures, for
example in electronic circuits, they
are less likely to escape this structure
and no human or environmental expo-
sure is likely to occur.’ Article 8(2) of
the Directive nevertheless states: ‘the
Commission is invited to evaluate
whether amendments to Annex VII
are necessary to address nanomaterials
contained in EEE.’ At the moment, no
action has been taken to amend Annex
VII — Selective treatment for materials
and components of waste electrical
and electronic equipment for
nanomaterials.
RoHS2 sets restrictions for the use of
hazardous materials in electrical and
electronic equipment. The directive
suggests that NMs should be consid-
ered when reviewing Annex II — List of
Restricted Substances. In 2012–2014,
the Environment Agency Austria
(Umweltbundesamt) wrote the meth-
odology for the review of the List of
Restricted Substances under RoHS2.23
The methodology does not prioritise
NMs among other materials, but sug-
gests caution in the assessment of such
substances. real-life relevant risk profile for a given
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Effective risk assessment and manage-
ment both assume a high degree of
information disclosure. In order to
focus on the risk assessment, stake-
holders, especially employees as well
as health and safety representatives in
the risk assessment are actively
involved. The employees have a good
understanding of their area of work
and the risks involved, so they are
entitled to an opinion on how safety
systems of work are designed, devel-
oped, monitored and assessed.
The information gathering process is
split up in two individual steps. The
starting point is the collection of gen-
eral information, which are important
with regard to nanosafety via a ques-
tionnaire survey (see Section
“Questionnaire survey” and Supple-
mentary information). In the second
step, companies are visited to gain
deep and detailed insight into real
working conditions on-site (see Sec-
tion “Company visits” and Supplemen-
tary information).
Questionnaire survey
A detailed questionnaire (see Supple-
mentary information) is shared with
technical experts and/or safety repre-
sentatives in order to identify all mate-
rials, processes, products and applica-
tions, which may be relevant in terms
of nanosafety. More precisely, this ini-
tial assessment involves identifying the
potential source(s) of manufactured
NMs emissions by reviewing the type
of process, process flow, material
inputs and discharges, and work
practices.
The elaborated safety strategy is
based on these case-by-case surveys,
addressing the specific requirements
of the involved parties (i.e., data on
the characteristics of the NMs, as well
as contextual information on the oper-
ative conditions and risk controls
applied). The filled-in questionnaires
will be evaluated and uncertainties
are going to be clarified.
Company visits
Analysis of the filled-in survey is com-
plemented by in-depth interviews at
the sites and/or face-to-face meetings
with industrial partners to get an
extensive impression of the on-site
working conditions. The visits a
include a guided tour through the
facilities, discussions with techn
developers, production experts as w
as health and safety managers. It 
valuable way of involving the staff w
do the work. They know the r
involved and scope for potentially d
gerous shortcuts and proble
Employees are more likely to und
stand why procedures are put in pl
to control risks and follow them if t
have beeninvolved indeveloping he
and safety practices in their workpl
As a next step, the companies 
asked to fill in a template to itemise
processes into every single process s
(see Supplementary information).
Hazard Assessment
Hazard assessment encompasses 
collection of all relevant and availa
information on the intrinsic proper
of the substance that may support
identification of hazardous proper
and critical effects.24
Thus, the collection of hazard d
includes information related to:
Physicochemical properties (e.g., ph
ical form, vapour pressure, dustin
solubility, nanomaterial concen
tion) provided by material safety d
sheets (MSDS), registration doss
for REACH; (ii) (Eco)toxicolog
outcomes (e.g., acute and chronic 
temic effects, genotoxicity, irritati
provided by case studies and/or p
reviewed publications, internal rep
regarding health and safety of N
(iii) Occupational and environme
benchmark/threshold limits (i.e., P
dicted no effect concentrat
(PNEC): Concentration of the s
stance below which adverse effect
the environmental sphere of conc
are not expected to occur; Derived N
Effect Level (DNEL): Level of ex
sure to a substance above wh
humans should not be exposed).
Particularly, the above-mentio
exposure limit values are crucial
they represent the reference val
for assessing whether risks are c
trolled. A risk score (i.e., risk cha
terisation ratio) is then calculated
comparing measured or estima
exposure levels and the PNECs 
the environment and DNELs 
human health.25Please cite this article in press as: Schi
nanomaterial. J. Chem. Health Safety (2
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Exposure Assessment
The objective of the exposure ass
ment phase is to identify exposure 
narios along the NMs lifecycle. Un
REACH, exposure scenarios co
manufacturing, all identified uses 
substance and all risks related to c
sumers, workers and the environm
arising from such uses, considering
use of the substance on its own
mixtures or in an articles as defi
by the identified uses.26
In order to cover as much of 
spectrum of likely releases as possi
usually more than one scenario nee
bedevelopedandmodelled—repres
ing e.g., low, mean (i.e., realistic), 
high release factors. Taken toget
these various scenarios can cover t
the entire value chain spectrum of p
sible releases (and environmental c
centrations) — and the related envir
mental impacts taken into acco
operational conditions and neces
risk management measures.
The exposure scenario mapp
plays a fundamental role within 
safety assessment, since it constitu
the basis for the exposure estima
and risk characterisation.26
Risk Characterisation
In order to prioritise previously ide
fied exposure scenarios, the first 
tool ECETOC TRA (=Targeted R
Assessment) is used. ECETOC T
was selected as a result of exten
literature research and discussi
with experts from NANoREG. 
integrated tool enables an assessm
of both occupational and environm
tal exposure scenarios. The mode
based on a relation between PRO
ERCs (process categories/envir
mental release categories descri
in the REACH guidance27) and b
exposure threshold values. In part
lar, the software calculates whether
potential for exposure in a spec
scenario is high or low.21,28,29 H
ever, it has to be considered that w
respect to nanomaterial exposu
ECETOC TRA is able to give an in
cation of exposure levels. Since E
TOC was not initially designed to s
cifically assess nanomaterial expos
situations, the risk estimates may
inaccurate due to the limitations
the model.30mpel, C. et al1., A methodology on how to cre
017), http://dx.doi.org/10.1016/j.jchas.2017.06.
Journal oate a real-life relevant risk profile for a given
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JCHAS-943; No of Pages 12The tool requires the user to input
some basic information on the sub-
stance (molecular weight, vapour pres-
sure, substance form). The user can
then select scenarios, as PROCs/ERCs,
which pre-define the point of depar-
ture exposure value. A range of expo-
sure modifiers are applied to establish
the set of operational conditions and
risk management measures that
appear in the final scenario (see Sup-
plementary information).
The output of ECETOC TRA is a
simple description of type and basic
conditions of use which can then be
translated into calculated risk values
via comparison of estimated data with
indicative reference values (DNEL,
OEL (occupational exposure limit), i.
e., maximum admissible concentration
at workplace, PNEC).
For each exposure scenario, the soft-
ware calculates different risk charac-
terisation ratios (RCR) according to
Eq. (1). To assess worker’s exposure,
short-term and long-term inhalative as
well as dermal RCRs are calculated. In
addition, a RCR for long term total
exposure is generated.
For environmental exposure assess-
ment, a separate RCR for each envi-
ronmental compartment is generated,
i.e., marine water, freshwater, soil and
sediment.
RCR human occupationalð Þ health
¼ exposure
DNEL
RCR environment
¼ PEC
PNEC
ð1Þ
A RCR value >1 indicates that there
is risk in place for human health or the
environment, while a value <1 means
that no risk is present under the
selected conditions.
Ideally, the exposure assessment
should be based on quantitative mea-
surements of the levels of the exposure,
however, in practice, the availability of
reliable exposure data is scarce and
mostly limited to the workplace. Use
of single tool estimates is unlikely to be
persuasive enough for appropriate risk
assessment. Hence, it has been recom-
mended to use different methods
for different risk-based decision con-
texts.30,31 Therefore, semi-quantitativePlease cite this article in press as: Schimpel,
nanomaterial. J. Chem. Health Safety (2017)
Journal of Chemical Health & Safety, May/Jassessment via ECETOC TRA is sup-
ported by qualitative assessment using
control banding tools (i.e., Stoffenma-
nager Nano and ISO/TS 12901-
2:2014) to evaluate, if risks are ade-
quately controlled in each pre-defined
exposure scenario.
Control banding tools represent an
alternative approach for risk assess-
ment that can be used to identify and
recommend exposure control mea-
sures to potentially hazardous sub-
stances with unknown or limited toxi-
cological properties and for which
there is a lack of quantitative exposure
estimations. Control banding tools
define hazard bands and exposure
bands and combine these in a two-
dimensional matrix, resulting in a
score for risk control (proactive
approach). Hazard banding consists
in assigning a hazard band to a sub-
stance on the basis of a comprehensive
evaluation of all available data on this
material (often from a Material Safety
Data Sheet, MSDS), taking into
account parameters such as toxicity,
and factors influencing the ability of
particles to reach and/or deposit in the
respiratory tract. (i.e., physical and
chemical properties such as surface
area, surface chemistry, shape, particle
size). Following the hazard banding
process, the second step is intended
to determine an expected level of
workers exposure which is designated
as an exposure band. Matching the
hazard band and the exposure band
through a control banding matrix
determines the appropriate level of
control i.e. the control band. The
greater the potential for harm and
exposure, the greater the steps needed
for control.32,33
The ISO/TS 12901-134 control
banding approach allocates five bands
for hazard, four bands for exposure
and five risk level control bands. Once
the hazard and exposure band are
determined, a control measure strategy
is suggested. This means that a sub-
stance with greater health hazards
and higher exposure potential will
have more stringent controls than a
substance with low health hazards.
Stoffenmanager Nano applies five
hazard bands, four exposure bands
(emission potential) and three control
bands for risk. The control bands C. et al1., A methodology on how to create a
, http://dx.doi.org/10.1016/j.jchas.2017.06.002
une 2017 (levels) are derived by combinations
of the hazard and exposure bands in
a two-dimensional decision matrix.
Each control band (risk level) is asso-
ciated with general recommendations
for risk management and action that
should be taken into
consideration.35,36
Refined Risk Characterisation and
Exposure Monitoring
When risk cannot reasonably be
excluded via qualitative and semi-
quantitative risk assessment, refined
risk assessment becomes necessary (i.
e., additional estimation based on
higher tier estimation models, genera-
tion of measured exposure data).
Field-based, real-time workplace
release and exposure measurements
will be performed according to the
OECD.37 The proposed approach
can be split into three tiers: At Tier 1
a decision has to be made, whether or
not a release of nanoscale aerosols
from NMs into workplace air can be
reasonably excluded. If this is not the
case, a basic exposure or release assess-
ment is conducted utilizing easy-to-
use, portable equipment/handheld
devices for direct reading measure-
ments (on-line) in Tier 2. Total particle
concentration (TPC) is measured dur-
ing the nano-related tasks and is com-
pared with background concentration;
if the comparison shows a significant
increase in TPC, then a potential
release of NMs due to the task may
happen and a Tier 3 is suggested. Tier 3
is an expert assessment where the use
of advanced on-line devices and the
collection of samples for off-line anal-
ysis are simultaneously combined.
Risk Management and Strategies for
Risk Mitigation
The main objective of this step is con-
sidering and incorporating safety mea-
sures of potential health (workers and
envisaged users) and environmental
safety concerns from the very begin-
ning/at earliest stage in the innovation
process and where necessary adapting
the process and/or product design so
as to create safer outcomes. Thus, risk
mitigation actions focus on hazard/
risk avoidance rather than address
them as an exposure (i.e., Safe-by-
Design). real-life relevant risk profile for a given
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Figure 1. Linkage of NanoSafety Cluster, European Pilot Production Network (EPPN) and projects contributing to the i2L group.
/
n-RESULTS AND DISCUSSION
Recommendations of the Organisation
for Economic Co-operation and
Development (OECD) for a responsi-
ble strategy that aims to enable the safe
development and use of NMs and
nanotechnology include the proposal
of integrating risk assessment of che-
micals at all stages of the life cycle of a
nanotechnology-based product.38
Within the European Parliament and
Council Regulation (EC) No 1907/
2006 (REACH), risk assessment and
risk characterisation is conducted
under the overall framework of the
chemical safety assessment (CSA) pro-
cess39 which basically encompasses
three steps:
1. Hazard Assessment: The hazard
assessment involves the analysis of
available data on (eco)toxicological
effects with respect to human health
and the environment;
2. Exposure Assessment: The expo-
sure assessment formulates expo-
sure scenarios describing how
a chemical is used by workers or
consumers or how it is released into
the environment (bearing in mind
operational conditions and ne
sary risk management measur
and,
3. Risk Characterisation: The risk ch
acterisation combines hazard 
exposure to estimate risk; risk le
are defined via comparing of e
mated exposure levels with thre
old/benchmark exposure limits.
In order to create a holistic 
cross-sectorial approach for 
nano-related safety assessment, 
concept is basically grounded on 
classical framework40 but has b
modified — now covering six steps
1. Information Gathering;
2. Hazard Assessment;
3. Exposure Assessment;
4. Risk Characterisation;
5. Refined Risk Characterisation 
Exposure Monitoring and
6. Risk Management and Strate
for Risk Mitigation.
In addition, the development of
proposed safety framework also inc
porates partnership and coordinat
between nanosafety experts, indust
and other stakeholder groups. OPlease cite this article in press as: Schi
nanomaterial. J. Chem. Health Safety (2
6 ces-
es);
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gies
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ries
ne
crucial step forward to better 
safety work and industry in ongo
projects was the establishment of 
NanoSafety Cluster sub-gr
“industrial innovation liaison (i2L
founded in September 2016 in Paris
brief, this group aims to maximise
synergies between ongoing nanosa
research and industry-oriented p
jects to identify possible cross-o
safety strategies/guidelines valid 
different sectors/markets, and to sh
“case study” experiences, includ
evaluation of which methodolog
guidelines are most useful and wh
knowledge gaps/limitations e
Additionally, this group will supp
technical development in the Eu
pean Pilot Production Netw
(EPPN) (see Figure 1).
There have been a number of c
plementary approaches proposed
evaluate the potential risks and
serve as decision support tools 
NMs/nano-enabled products.41
order to assess the advantages 
limitations of existing RA framewo
6http://www.nanosafetycluster.eu
working-groups/industrial-innovatio
liaison-i2l-wg10.html.mpel, C. et al1., A methodology on how to create a real-life relevant risk profile for a given
017), http://dx.doi.org/10.1016/j.jchas.2017.06.002
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JCHAS-943; No of Pages 12and tools, as a first step we conducted
an extensive literature survey to collect
information from completed and
ongoing European research projects
or by other international organisations
and committees to ensure consistency
at EU level and alignment to the state-
of-the-art.
The most important sources of
knowledge from relevant research pro-
jects (including the most recent and
relevant publications and nanoEHS
tools) are outlined in Table 1.
As indicated in the table above, sev-
eral approaches exist for risk estima-
tion; however, none of these concepts
represent a seamless strategy to effec-
tively manage the multidisciplinary
nature of nanotechnology and theirPlease cite this article in press as: Schimpel,
nanomaterial. J. Chem. Health Safety (2017)
Figure 2. Overview o
Journal of Chemical Health & Safety, May/Jrelated risks. Carrying out risk assess-
ment is strongly depended on informa-
tion and data availability (e.g., nano-
specific exposure data/limits).28 Tak-
ing into account that recently a wide
variety of NMs (e.g., raw materials,
intermediate components) and nano-
technology-enabled consumer pro-
ducts are in the pipeline, we do not
have the luxury to investigate every
aspect of nanomaterial toxicity.53
Nanotechnology is reality now.
Responding to this challenge, we
decided to focus on immediate safety
measures. Thus, the main goal of our
safety concept is the development of an
instant plan/safety strategy for indus-
try workers which are handling NMs
by a day-to-day basis. The primary C. et al1., A methodology on how to create a
, http://dx.doi.org/10.1016/j.jchas.2017.06.002
f the different phases of the suggested nan
une 2017 objective is to protect human health
as well as the environment even in the
absence of complete information,
without stifling innovation. As indi-
cated in Figure 2, the proposed safety
concept follows the general REACH
(CSA) approach applied to chemicals
but is strongly moving towards a joint
application of risk/safety assessment
and life cycle assessment. Moreover,
a strong focus is placed on “objective
research” which suggests that the
nature of the risk can be properly
defined by making best usage of avail-
able data and involvement of highly
renowned players in the research and
industrial field and other stakeholders
(e.g., active bodies in regulation/stan-
dardization). Combining collected real-life relevant risk profile for a given
osafety concept.
7
and
in
its
tive
, as
an
on
the
nd-
ano
an-
OC
ow-
ties
om-
s of
ble
pe-
tion
its
and
olu-
ing
ach
wl-
tify
tion
itial
her
ally
ach
tua-
no-
 (Q)
 the
JCHAS-943; No of Pages 12
Table 1. Selection of State-of-the-Art RA Frameworks and Tools (in Alphabetica
Order).
Framework Reference
GuideNano http://www.guidenano.eu/
ITSnano Stone et al.42
LICARA Som et al.43
MARINA Framework Bos et al.44; http://www.marina-fp7.eu/
NANEX/MARINA Sikorova´ et al.45; http://www.nanex-project.eu/
NanoValid http://www.nanovalid.eu/
REACHnano http://www.lifereachnano.eu/
RIP-oN 3 Report Aitken et al.17
Scaffold http://scaffold.eu-vri.eu/
SUN Malsch et al.46; http://www.sun-fp7.eu/
Tools Reference
ANSES Tool Brouwer33
ConsExpo Bremmer et al.47
Control Banding Tool
(ISO/TS 12901-2:2014)
ISO34
ECETOC TRA Tool ECETOC21
GuideNano Tool http://www.guidenano.eu/
LICARA NanoScan Van Harmelen et al.48
NanoRiskCat Hansen et al.49
NanoSafer Jensen et al.50
REACHnano ToolKit REACHnano Consortium28
SimpleBox4Nano Meesters et al.51
Stoffenmanager Nano Van Duuren-Stuurman et al.19
Swiss Precautionary Matrix Hoeck et al.52hazard data with identified exposure
scenarios (i.e., exposure assessment
step) the result obtained is a library
of critical hotspots associated with ini-
tial exposure estimates (i.e., risk char-
acterisation/prioritisation stage).
For the calculation of risk values 
definition of the likelihood of rele
three tools were selected for qualita
and semi-quantitative risk assessm
respectively. General descriptio
background information relatedPlease cite this article in press as: Schi
nanomaterial. J. Chem. Health Safety (2
8 and
ase,
tive
ent
ns/
 to
elaboration and refinement is cruci
needed. Furthermore, the appro
can also be used to identify those si
tions/processes where the use of na
specific read-across, grouping, and
SAR is likely to become realistic inmpel, C. et al1., A methodology on how to cre
017), http://dx.doi.org/10.1016/j.jchas.2017.06.
Figure 3. Current vs future safety conce
Journal othe tools, the selection criteria 
obtained results are outlined 
Table 2.
As long as data and exposure lim
for NMs are not available, quantita
risk assessment is not feasible. Thus
a starting point we established 
immediate safety concept based 
qualitative risk assessment via 
ISO/TS 12901-2:2014 Control Ba
ing Tool and the Stoffenmanager N
Tool on the one hand, and semi-qu
titative risk assessment using ECTE
TRA on the other. In the future, h
ever, the objective is shifting priori
over time from a safety strategy c
pliant with the current provision
REACH to an effective and sustaina
safety concept which allows nano-s
cific quantitative exposure estima
(built on nano-specific exposure lim
and measurement principles) 
which will adapt to the future ev
tions of REACH annexes regard
NMs (see Figure 3).
In summary, the proposed appro
is based on the current state of kno
edge and is flexible enough to iden
critical hotspots along the innova
chain/life cycle associated with in
exposure estimates. However, furt
late a real-life relevant risk profile for a given
002
pt.
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Table 2. Overview of Selected Risk Assessment Tools Included in the Nanosafety Concept.
Qualitative Risk Assessment Tools Semi-Quantitative Risk
Assessment Tool
Name ISO/TS 12901-2:2014
(Control Banding)34,54
Stoffenmanager Nano
(Control Banding)19,35
ECETOC TRA (Targeted Risk
Assessment) Tool55
Description - Approach addressing likelihood of release, based on limited
amount of information
- Approach for calculating risk
values via comparison of
estimated data with indicative
reference values, based on
mandatory inputs related to
physicho-chemical properties,
operational settings, RMM
- Hazard/exposure potentials are measured on scales called “bands”
 Bands are typically plotted on a two-dimensional matrix, which
results in establishing a control band (ISO) or a risk band
(Stoffenmanager Nano)
 Risk control is achieved through recommendations of
appropriate risk management measures (RMM) (e.g.,
engineering and administrative controls) as well as personal
protective equipment (PPE)
General
Structure
- Information gathering - Information gathering
- Assignment of nanomaterial to a Hazard Band ! hazard banding - Definition of exposure scenarios
(taking into account operational
conditions, RMM)
- Description of potential exposure characteristics ! exposure
banding
- Assignment of scenarios to a
PROCs/ERCs (process
categories/environmental
release categories described in
the REACH guidance)
- Definition of recommended work environments and handling
practises ! control banding
- Final output is a library of critical
hotspots associated with initial
exposure estimates
- Evaluation of the control strategy (action plan) based on the
chosen scenario
Output - Hazard band (HB) - Hazard band (HB) - Risk characterisation ratio (RCR)
- Exposure Band (EB) - Exposure Band (EB)
- Control Band (CB) - Risk Band (RB)
Selection
Criterion
U Standardised ISO-
guideline
U Real case study tested (e.g., EU-
funded project SCAFFOLD)
U Real case study tested (e.g.,
EU-funded project
NANoREG)56
U Usable in the absence of
exposure and
benchmark limits
U Nano-specifity U Compliant with REACH
regulation (i.e., using the ECHA
use descriptor system)
U Applicable in the absence of
exposure and benchmark limits
U Considers occupational,
environmental & consumer
exposure
U Stoffenmanager1 is included in
the official REACH Guidance
(R.14) document as a
recommended tool. Meaning
the European Commission
officially recognizes
Stoffenmanager as instrument
to comply with the REACH
regulation
U Not only qualitative risk
asessemnt, but also semi-
quantitative risk profiling,is
feasible
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JCHAS-943; No of Pages 12future, since conducting risk assess-
ment for each individual nanomaterial
on a case-by-case basis would require a
lot of resources as well as time, effort,
and money.
CONCLUSIONS
This outlined Methodology on How to
Create a Real-life relevant Risk Profile
for a Given Nanomaterial relates to
existing risk assessment practice under
the current regulatory framework for
the safe use of chemicals (i.e., REACH)
and its future evolution towards an
inclusion of provisions for nanoforms
in ECHA guidance documents and a
revision of REACH annexes to specifi-
cally address NMs.
The present paper gives guidance on
how to create a risk profile for a given
nanomaterial (e.g., determine which
materials and/process operation pose
greater risk, where these risks occur in
the lifecycle, and the impact of these
risks) using state-of-the-art safety
assessment approaches/tools (ECE-
TOC TRA, Stoffenmanager Nano and
ISO/TS 12901-2:2014). It focuses on
giving concrete, practical guidance to
industry and regulatory authorities
(such as European agencies, scientific
committees, national competent
authorities) on how to deal with envi-
ronmental health and safety aspects
(EHS) when dealing with NMs and
nano-enabled products.
NMs manufacturers need to stay in
phase with the latest evolutions of the
legislative framework for NMs. Cur-
rently, the overarching European
chemical regulation, REACH, is
undergoing adaptation of its annexes
to clarify nanomaterial requirements.
At the same time we see European
Member States continue setting up
national nanomaterial registers. In this
context, putting NMs in the European
market has become increasingly diffi-
cult and costly, thus significantly ham-
pering the innovation potential of the
region.
Some of the nanosafety projects
(NANoREG, NanoReg2, ProSafe)
financed by the European Union
intend to support regulation; these col-
lect large quantities of comparable and
consolidated data on toxicological
endpoints. This is a first step towa
a facilitated use of grouping and re
across for NMs, thus improving 
quality of dossiers and reducing th
cost. At international level the OE
is actively supporting grouping 
read-across for NMs57 and underta
continued efforts to deliver a sust
able policy framework that ensu
safe products and a positive envir
ment for innovation.
The presented approach may 
valuable both for policy makers/re
lators and as well as industry. Po
makers/regulators can predomina
benefit from using the concept to pr
itise those NMs and/or applicati
that need to be addressed m
urgently. Industry can use 
approach as a forward-looking st
egy aiming at making safety assessm
practical and economically efficien
However, it needs to be emphasi
that the field of nanomaterial 
assessment is evolving, and the me
odology provided is based on the c
rent available knowledge develope
diverse European research proj
and other international organisati
and committees. In the future, 
methodology presented in this art
may therefore be revised in the ligh
new scientific knowledge.
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